Product Information
CLONAZEPAM 0.25 MG ODT is a generic product labeled by Par Health USA, LLC, priced at $0.4385 per EA under NDC 49884030702. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 3, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
Par Health USA, LLCNDC
49884030702
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077171FDA Approved
8/3/2005
TE Code
AB
On Market Since
8/5/2005
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.25 MG ODT has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4385 per EA |
|---|---|
| All-time high | $0.8007 (May 11, 2022) |
| All-time low | $0.3522 (Jan 17, 2024) |
| 52-week high | $0.6792 |
| 52-week low | $0.4331 |
| Median price | $0.6834 |
| Average price | $0.6415 |
| Largest weekly change | +52.3% (Feb 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clonazepam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Par Health USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clonazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.25 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.25 MG ODT, manufactured by Par Health USA, LLC, is $0.4385 per EA (NDC 49884030702), effective Sep 30, 2026.
How has the price of CLONAZEPAM 0.25 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.25 MG ODT has declined 39.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.25 MG ODT?
Since Nov 28, 2013, the NADAC for CLONAZEPAM 0.25 MG ODT has ranged from a low of $0.3522 (Jan 17, 2024) to a high of $0.8007 (May 11, 2022), with a median of $0.6834 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.25 MG ODT?
No other NADAC-published product currently shares the active ingredient and strength of CLONAZEPAM 0.25 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLONAZEPAM 0.25 MG ODT?
CLONAZEPAM 0.25 MG ODT (NDC 49884030702) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.